a GSK , Bogotá , Colombia.
b GSK , Panamá City , Panamá.
Hum Vaccin Immunother. 2018 May 4;14(5):1230-1233. doi: 10.1080/21645515.2018.1425115. Epub 2018 Feb 12.
Colombia introduced mass pneumococcal conjugate vaccination at the end of 2011. Using 2005-2015 surveillance data, we conducted a retrospective interrupted time-series analysis. A significant trend towards reduced monthly was observed in the post-vaccination period (2012-2015) compared with the expected rate, reaching in 2015 a reduction of 90.5% of pneumococcal meningitis. This trend was not observed for control diseases.
哥伦比亚于 2011 年底推出了大规模肺炎球菌结合疫苗接种。利用 2005-2015 年的监测数据,我们进行了回顾性中断时间序列分析。与预期相比,在接种疫苗后(2012-2015 年),每月发病率呈显著下降趋势,到 2015 年,肺炎球菌性脑膜炎发病率下降了 90.5%。这一趋势在对照疾病中并未观察到。